StemCells, Inc. to Present on Batten Disease to the California Institute of...
Centre Daily Times: 4 views since Friday, August 8, 2008 at 07:54 AM
StemCells, Inc. (NASDAQ:STEM) today announced that it has accepted an invitation by the California Institute of Regenerative Medicine (CIRM) to present on Batten Disease at the upcoming meeting of CIRM's Independent Citizens Oversight Committee (ICOC). At the meeting, Ann Tsukamoto, Ph.D., the Company's Chief Operating Officer, and Stephen Huhn, M.D., F.A.C.S., F.A.A.P., Vice President and Head ...

Published in: Medicine